Seminar

Update on recent initiatives of the European Commission on SPC

Update on recent initiatives of the European Commission on SPC

Update on recent initiatives of the European Commission on SPC

22.03.2016

In October 2015, the European Commission issued “A Single Market Strategy for Europe” COM(2015) 550 final. One of goals of this strategy is to consolidate Europe’s IP framework. For the pharmaceutical industry, the question arises as to how the upcoming unitary patent will work together with the national SPCs.

The Commission indicated that it will consider initiatives:

  • To address uncertainties about how the unitary patent will work together with current EU rules on SPCs;
  • In relation to the scope of the ‘Bolar’ and research exemptions in view of the upcoming establishment of the Unified Patent Court;
  • To introduce targeted SPC manufacturing waiver for export purposes.

That is why our Brussels life sciences experts are organising a seminar dedicated to these important topics. The seminar aims to present to present the current legal landscape and legal implications of the foreseen developments at both European and international levels to professionals of the pharmaceutical industry.

Below you will find an outline of the main topics that are discussed during the seminar.

 

Team

Related news

20.11.2018 NL law
Seminar 'Personal data from a broader perspective: overlap inside and outside the privacy domain'

Seminar - On 20 November 2018, Stibbe will host a seminar on privacy. Several Stibbe lawyers will discuss personal data from a broader perspective and the overlap that can occur inside and outside the legal privacy domain.

Read more

21.03.2019 EU law
Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference.

Speaking slot - Ignace Vernimme, IP Partner at Stibbe Brussels, moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini, of-counsel at Stibbe Brussels, co-moderates this session. Floris ten Have, Competition and Regulation Partner at Stibbe Amsterdam, chairs a session on opportunities and challenges for biosimilar medicine developers.

Read more

21.03.2019 NL law
15 aspects of Brexit you did not know

Short Reads - A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario.

Read more

03.10.2018 NL law
Thirteen legal tips for start-ups and scale-ups -Takeaways from Stibbe's 'Scale Up Academy Accenture Innovation Awards' legal workshop

Articles - On Thursday August 30, Stibbe, in cooperation with Accenture Innovation Awards 2017 finalist Somnox, hosted a legal workshop as part of the 'Scale Up Academy of the Accenture Innovation Awards'. The purpose of the event was to make start-ups and scale-ups aware of the legal challenges that may arise in their infancy. 

Read more

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring